Acute Upper Airway Obstruction Secondary to Retained Respiratory Secretions in a Patient with SARS-CoV-2 Respiratory Failure Treated with Prolonged CPAP

Vol 6 | Issue 3 | September-December 2020 | Page — | David Jones, Veena Surendrakumar, Ismail Vokshi, Nicholas Oscroft


Author: David Jones [1], Veena Surendrakumar [1], Ismail Vokshi [1], Nicholas Oscroft [1]

[1] Department of Anaesthesia, Royal Papworth Hospital,
Cambridge, UK.

Address of Correspondence
Dr. David Jones
Royal Papworth Hospital, Cambridge, UK.
E-mail: David.jones69@nhs.net


Acute Upper Airway Obstruction Secondary to Retained Respiratory Secretions in a Patient with SARS-CoV-2 Respiratory Failure Treated with Prolonged CPAP


Abstract

SARS-CoV-2 is a novel coronavirus which can cause respiratory failure requiring ventilatory support. We describe the first documented case of life-threatening upper airway obstruction due to retained secretions around a nasogastric (NG) tube in a patient suffering with this disease who was managed with prolonged continuous positive airways pressure (CPAP). This case highlights the need for awareness around the development of an upper airway mass due to tenacious secretions in SARS-CoV-2 positive patients and the need to develop preventative strategies in order to prevent avoidable mortality.
Keywords: Airway obstruction; CPAP; SARS-CoV-2; Coronavirus; Nasogastric tube; Non-invasive ventilation.


References

1. World Health Organization [Internet]. WHO Timeline – COVID-19. 27th April 2020. [Cited 22nd May 2020]. Available from https://www.who.int/newsroom/ detail/27-04-2020-who-timeline—covid-19
2. Intensive care national audit & research centre (ICNARC) [Internet]. COVID-19 Report. 15th May 2020. [Cited 22nd May 2020]. Available from https://www.icnarc.org/Our-Audit/Audits/Cmp/Reports
3. GOV.UK [Internet]. Coronavirus (COVID-19) in the UK. 21st May 2020. [Cited 22nd May 2020]. Available from https://coronavirus.data.gov.uk/
4. Sanders JM, Monogue ML, Jodlowski TZ, Cutrell JB. Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review [published online ahead of p r i nt , 2 0 2 0 A p r 1 3 ] . J A M A . 2 0 2 0 ; 1 0 . 1 0 0 1 / j a m a . 2 0 2 0 . 6 0 1 9 . doi:10.1001/jama.2020.6019
5. NHS England and NHS Improvement. Guidance for the role and use of non-invasive respiratory support in adult patients with COVID-19 (confirmed or suspected). Speciality guides for patient management during the coronavirus pandemic, 2020. [Cited 19th June 2020] Available from https://www.england.nhs.uk/coronavirus/wpcontent/ uploads/sites/52/2020/03/specialty-guide-NIV-respiratory-supportand- coronavirus-v3.pdf.
6. K. Rockwood et al. A global clinical measure of fitness and frailty in elderly people. CMAJ 2005; 173:489-495.
7. Resuscitation Council (UK) [Internet]. ReSPECT. c2014-2020. [cited 22nd May 2020]. Available from: https://www.resus.org.uk/respect/
8. Rubano JA, Jasinski PT, Rutigliano DN, et al. Tracheobronchial Slough, a Potential Pathology in Endotracheal Tube Obstruction in Patients with Coronavirus Disease 2019 (COVID-19) in the Intensive Care Setting [published online ahead of print, 2020 May 20]. Ann Surg. 2020;10.1097
9. General Medical Council [Internet]. Cardiopulmonary resuscitation. c2020. [cited 22nd May 2020]. Available from: https://www.gmc-uk.org/ethicalguidance/ethical-guidance-for-doctors/treatment-and-care-towards-the-end-oflife/ cardiopulmonary-resuscitation-cpr


How to Cite this Article: Jones D, Surendrakumar V, Vokshi I, Oscroft N | Acute Upper Airway Obstruction Secondary to Retained Respiratory Secretions in a Patient with SARS-CoV-2 Respiratory Failure Treated with Prolonged CPAP | Journal of Anaesthesia and Critical Care Case Reports | September-December
2020; 6(3): —.

(Abstract) (Text HTML) (Download PDF)